Heaven Sent Naturals, affiliates have been acquired by Wellgenix LLC/Red Oak Capital PE
The private shareholders of Heaven Sent Naturals, Puri-Clean and Covert Labs have sold a 51.5% stake in the companies, to Red Oak Capital, a Texas-based investment company that has made a wide range of investments and focuses on profitable companies, for US$25.54 million.
Heaven Sent Naturals, Puri-Clean and Covert Labs are three related companies in the nutritional supplement industry. Their products are sold in numerous independent and health food chain stores across the USA. The shareholders had built the company from a start-up to its present size over a 15-year period and recognized the need for additional expertise to take the company through the next growth stage.
Oaklins' team in Dallas advised the seller in this transaction, which was structured to deliver cash proceeds of 66% at closing and the remaining 33% to be paid annually over the next 5 years.
Talk to the deal team
Bryan Livingston
Oaklins Capital Alliance
Related deals
The Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn moreSt. Claraspital AG has been acquired by University Hospital Basel
University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).
Learn moreRAM Infotechnology has acquired Interoperability Group with support from Keensight Capital
RAM Infotechnology (RAM-IT) has acquired Interoperability Group, a leading Dutch provider of healthcare IT solutions, with the support of Keensight Capital, a leading European growth buy-out investor specializing in technology and healthcare.
Learn more